These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6159969)

  • 1. Inhibition of sulfate conjugation of N-hydroxy-2-acetylaminofluorene in isolated perfused rat liver and in the rat in vivo by pentachlorophenol and low sulfate.
    Meerman JH; van Doorn AB; Mulder GJ
    Cancer Res; 1980 Oct; 40(10):3772-9. PubMed ID: 6159969
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol.
    Meerman JH; Beland FA; Mulder GJ
    Carcinogenesis; 1981; 2(5):413-6. PubMed ID: 7273322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the hepatotoxic action of N-hydroxy-2-acetylaminofluorene in the rat by inhibition of N-O-sulfation by pentachlorophenol.
    Meerman JH; Mulder GJ
    Life Sci; 1981 May; 28(21):2361-5. PubMed ID: 7253825
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 5. The initiation of gamma-glutamyltranspeptidase positive foci in the rat liver by N-hydroxy-2-acetylaminofluorene. The effect of the sulfation inhibitor pentachlorophenol.
    Meerman JH
    Carcinogenesis; 1985 Jun; 6(6):893-7. PubMed ID: 2860981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic studies on in vivo covalent binding of N-hydroxy-2-acetylaminofluorene in rat liver containing gamma-glutamyltranspeptidase-positive foci. The effect of the sulfation-inhibitor pentachlorophenol.
    Kroese ED; Tijdens RB; Mulder GJ; Meerman JH
    Carcinogenesis; 1987 Apr; 8(4):571-5. PubMed ID: 2881632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beland FA; Dooley KL; Jackson CD
    Cancer Res; 1982 Apr; 42(4):1348-54. PubMed ID: 6949639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glutathione depletion on the hepatotoxicity and covalent binding rat liver macromolecules of N-hydroxy-2-acetylaminofluorene.
    Meerman JH; Tijdens RB
    Cancer Res; 1985 Mar; 45(3):1132-9. PubMed ID: 2578873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of sulfation in the metabolic activation of N-hydroxy-4'-fluoro-4-acetylaminobiphenyl.
    van de Poll ML; Tijdens RB; Vondrácek P; Bruins AP; Meijer DK; Meerman JH
    Carcinogenesis; 1989 Dec; 10(12):2285-91. PubMed ID: 2480190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ascorbic acid on in vitro mutagenicity and in vivo covalent binding of N-hydroxy-2-acetylaminofluorene in the rat.
    Thorgeirsson SS; Sakai S; Wirth PJ
    Mutat Res; 1980 May; 70(3):395-8. PubMed ID: 6155610
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of sulfotransferase inhibitors on the 2-acetylaminofluorene-mediated lowering of rat liver N-hydroxy-2-acetylaminofluorene sulfotransferase activity.
    Ringer DP; Norton TR; Kizer DE
    Biochem Pharmacol; 1985 Sep; 34(18):3380-3. PubMed ID: 3862410
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulfation of N-hydroxy-2-acetylaminofluorene in normal and nodular liver from male Wistar rats.
    Blanck A; Wicksell L; Eriksson LC
    Toxicol Pathol; 1987; 15(1):103-5. PubMed ID: 3576071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyltransferase-mediated binding of N-hydroxyarylamides to nucleic acids.
    Beland FA; Allaben WT; Evans FE
    Cancer Res; 1980 Mar; 40(3):834-40. PubMed ID: 7471100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of N-hydroxy-2-acetylaminofluorene-DNA adducts in rat liver measured by radioimmunoassay.
    Rio P; Bazgar S; Leng M
    Carcinogenesis; 1982; 3(2):225-7. PubMed ID: 6978201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention by thioethers of the hepatotoxicity and covalent binding to macromolecules of N-hydroxy-2-acetylaminofluorene and its sulfate ester in rat liver in vivo and in vitro.
    van den Goorbergh JA; de Wit H; Tijdens RB; Mulder GJ; Meerman JH
    Carcinogenesis; 1987 Feb; 8(2):275-9. PubMed ID: 2433070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of reactive metabolites of the carcinogen N-hydroxy-2-acetylaminofluorene to DNA and protein in isolated rat liver nuclei: effects of glutathione and methionine.
    Meerman JH; Tijdens RB; Mulder GJ
    J Biochem Toxicol; 1986 Jun; 1(2):1-10. PubMed ID: 3271873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in sulfation and glucuronidation of phenol, 4-nitrophenol and N-hydroxy-2-acetylaminofluorene in the rat in vivo.
    Meerman JH; Nijland C; Mulder GJ
    Biochem Pharmacol; 1987 Aug; 36(16):2605-8. PubMed ID: 3606659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of sulfation in the rat in vivo and in the perfused rat liver.
    Mulder GJ
    Fed Proc; 1986 Jul; 45(8):2229-34. PubMed ID: 3087784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver.
    Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1981 Mar; 19(2):337-44. PubMed ID: 6939968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.